Legislative Action Needed to Reduce Burden of Cancer on Iowans

January 8, 2024

DES MOINES, Iowa - Statement from Jackie Cale, American Cancer Society Cancer Action Network (ACS CAN) Iowa government relations director:
“As lawmakers dive into the 2024 legislative session, ACS CAN urges legislators to prioritize passing legislation to ease the burden of cancer on Iowans. According to the 2023 Cancer in Iowa report, Iowa has the 2nd highest incident rate for cancer in the U.S. and is the only state with an increasing rate of cancer.

“ACS CAN calls on the legislature to improve coverage of comprehensive biomarker testing, a game changer in the fight against cancer. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to better diagnose and treat diseases like cancer. Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment, and legislators have an opportunity to fix that this session.

“Over 20,400 Iowans will be diagnosed with cancer this year. Ensuring patients who could benefit have access to biomarker testing gives them the information they need to best treat their cancer.” ### About ACS CAN The American Cancer Society Cancer Action Network (ACS CAN) makes cancer a top priority for policymakers at every level of government. ACS CAN empowers volunteers across the country to make their voices heard to influence evidence-based public policy change that improves the lives of people with cancer and their families. We believe everyone should have a fair and just opportunity to prevent, find, treat, and survive cancer. Since 2001, as the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we know it, for everyone. Join the fight by visiting

More Press Releases AboutAccess to Biomarker Testing, Iowa